Viewing nowMonorova Tablet 20 Milligrams (Rosuvastatin Calcium)
Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Yuhan Corporation

MFDS item code 201400111 · Approved 2014.01.10 · Insurance code 642104420
Treatment for hypercholesterolemia and reduced risk of cardiovascular disease
This medication is used as an adjunct when dietary measures and exercise are insufficient for controlling primary hypercholesterolemia and mixed dyslipidemia. It is particularly beneficial for patients with heterozygous familial hypercholesterolemia or dysbetalipoproteinemia. It lowers total cholesterol and LDL-cholesterol levels, delaying the progression of atherosclerosis and reducing the risk of cardiovascular disease. Additionally, it is suitable for some pediatric patients aged 10 to 17 years and serves as a safe dietary supplement. It reduces the risk of stroke, myocardial infarction, and arterial revascularization in middle-aged and elderly patients with high hypersensitive C-reactive protein levels and additional cardiovascular risk factors. Overall, this medication is used to improve the risk of various cardiovascular diseases associated with dyslipidemia.
The medication is taken once daily at any time regardless of meals. The initial dose is 5 milligrams, and adjustments can be made at intervals of 4 weeks or more according to treatment goals. Generally, the maintenance dose is 10 milligrams, with a maximum increase to 20 milligrams.
For pediatric patients aged 10 to 17 years, the dosage is 5 to 20 milligrams once daily. The dosage should be adjusted individually according to the treatment goals, and adjustments should be made at intervals of 4 weeks or more. For children under 10 years old, safety and efficacy have not been established.
This medication should not be used in certain patients. First, it should not be administered to patients with a known allergy to this medication, those with severely impaired liver function, patients with muscle disorders, and those with significantly reduced kidney function. Additionally, it should not be used by pregnant or nursing women, or women of childbearing age who are not using effective contraception. The 40 milligrams dosage is contraindicated for patients at high risk for muscle disorders. Caution should be exercised in patients who consume large amounts of alcohol or have a history of liver disease. Liver function tests should be repeated before and during administration, and any thyroid dysfunction or nephrotic syndrome should be treated prior. If symptoms such as myalgia, muscle weakness, or cramps occur during treatment, immediate medical attention should be sought. In particular, if there is a significant increase in muscle enzyme levels, the medication should be discontinued, and it can be restarted at a lower dose once symptoms improve. This medication may interact with certain drugs, so it is essential to consult a healthcare provider about any medications being taken concurrently. Particularly, concomitant use with certain antiviral agents, immunosuppressants, some antibiotics, and fibrate class drugs may increase the risk of muscle-related side effects. This medication should be avoided during pregnancy due to potential risks to the fetus, and it is also advisable to avoid use during lactation. In cases of overdose, there are no specific antidotes, so treatment should be symptomatic, and liver and muscle function tests are required. Patients may experience dizziness while on this medication; therefore, caution is advised when driving or operating machinery. Finally, this medication can rarely cause severe skin reactions, liver dysfunction, or muscle damage, so any abnormal symptoms should be reported to healthcare professionals immediately.
Hives, severe swelling (angioedema), chest tightness, breathing difficulties, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS) with elevated eosinophils and generalized symptoms, jaundice, hepatitis, severe liver failure, severe allergic reaction, severe skin reaction, rhabdomyolysis, immune-mediated necrotizing myopathy, ocular myasthenia gravis, severe muscle weakness, acute renal failure, oliguria, increased serum creatinine, and elevated blood pressure.
Not everyone experiences these, and they can vary from person to person.
This medication can be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is advisable to maintain a storage temperature between 1 to 30 degrees Celsius. This will help preserve the medication's effectiveness for an extended period.
Pink round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Yuhan Corporation

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.